AFCISBO
LIVE

Serial Number

79386142

Owner

SANDOZ AG

Filing Date

Oct 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AFCISBO Trademark

Serial Number: 79386142 • Registration: 7445435

AFCISBO is a trademark filed by SANDOZ AG on October 31, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANDOZ AG (208 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

October 31, 2023

Registration Date

July 16, 2024

Published for Opposition

April 30, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 22, 2025 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 15, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 R.PR
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTICE OF PUBLICATION
Apr 10, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2024 CNSA
ASSIGNED TO EXAMINER
Mar 21, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 28, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR